This indicates that ROMA + PD-1+Tim3+ offers a better balance between the ability to correctly detect malignant cases and to avoid false positives; furthermore, the higher AUC reflects a higher overall diagnostic accuracy, making this combination the most robust for discrimination between malignant and benign tumors. The gene discussed is HAVCR2; the disease is benign neoplasm.